Venture Planning Group
Venture Planning Group Market Research Reports
| Title | published | price | |
|---|---|---|---|
Succeeding in the Global Pseudomonas Testing Market, 2019-2023: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pseudomonas definition, epidemiology and etiology are reviewed. The repo ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Rabies Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Rabies diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rabies definition, epidemiology and etiology are reviewed. The report provide ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Rhinovirus Testing Market, 2019-2023: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Rotavirus Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Rotavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rotavirus definition, epidemiology and etiology are reviewed. The report p ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Respiratory Syncytial Virus (RSV) Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology an ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Rubella Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report prov ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Salmonella Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The repor ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Septicemia Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Septicemia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Septicemia definition, epidemiology and etiology are reviewed. The report ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Shigella Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Shigella definition, epidemiology and etiology are reviewed. The report pr ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Streptococci Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition, epidemiology and etiology are reviewed. The re ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Syphilis Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report pr ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Toxoplasmosis Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Tuberculosis (TB) Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The re ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Vibrio Testing Market, 2019-2023: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition, epidemiology and etiology are reviewed. The report provide ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Yersinia Testing Market, 2019-2023: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesBy Venture Planning Group
The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report pro ... |
25-Jun-2019 | $4350 | |
Succeeding in the Global Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: US, Europe, Japan--Sales and Market Shares of Major Suppliers by Test and CountryBy Venture Planning Group
This unique report from VPGMarketResearch provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic assessmen ... |
25-Jun-2019 | $7450 | |
Succeeding in the Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: France, Germany, Italy, Spain, UK--Sales and Market Shares of Major Suppliers by Test and CountryBy Venture Planning Group
This unique report from VPGMarketResearch provides Europe sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic as ... |
25-Jun-2019 | $5450 | |
Succeeding in the France Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: Sales and Market Shares of Major Suppliers by TestBy Venture Planning Group
This unique report from VPGMarketResearch provides France sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of ... |
25-Jun-2019 | $2800 | |
Succeeding in the Germany Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: Sales and Market Shares of Major Suppliers by TestBy Venture Planning Group
This unique report from VPGMarketResearch provides Germany sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments o ... |
25-Jun-2019 | $2650 | |
Succeeding in the Italy Blood Typing, Grouping and Infectious Disease NAT Screening Market, 2019-2023: Sales and Market Shares of Major Suppliers by TestBy Venture Planning Group
This unique report from VPGMarketResearch provides Italy sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of ... |
25-Jun-2019 | $2500 | |
- + 1 888 391 5441
- [email protected]
